On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...